Pertussis Completed Phase 2 Trials for Bordetella pertussis fimbriae 2/3 antigen (DB10790)

Also known as: Whooping cough due to Bordetella pertussis / Whooping Cough / Whooping cough due to bordetella pertussis (B. pertussis)

IndicationStatusPhase
DBCOND0014696 (Pertussis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00355121Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®Prevention
NCT00362427Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar®Prevention